Usefulness of Combined Functional Assessment by Cardiac Magnetic Resonance and Tissue Characterization Versus Task Force Criteria for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy.
Current task force criteria (TFC) of cardiac magnetic resonance (CMR) for the diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC/D) were generated by comparing probands (mean age of 44 years) to healthy participants of the multi-ethnic study of atherosclerosis (mean age of 60 years). These age differences may be a selection bias because right ventricular end-diastolic volume index decreases 4.6% per decade. Moreover, fat infiltration and late gadolinium enhancement were not included. We evaluated the diagnostic accuracy of TFC using the same methodology used by the task force but comparing probands and age- and gender-matched healthy controls and considering also other morphofunctional and tissue abnormalities detected by CMR. Forty-seven probands with previous diagnosis of ARVC/D (excluding probands if CMR was used for diagnosis) were compared with 216 age- and gender-matched healthy controls. TFC had optimal specificity (100%) but poor sensitivity (20% for major and 13% for minor criteria). The presence of any pre- and post-contrast signal abnormalities had 100% specificity and 81% sensitivity. The best diagnostic accuracy (98%) was achieved by the combined evaluation of any right ventricular wall motion abnormality (excluding hypokinesia) with any signal abnormality (including left ventricular fat infiltration and late gadolinium enhancement) yielding a 100% specificity and 96% sensitivity. Left ventricular was involved in 45% of the probands. Current TFC for CMR presented optimal specificity but poor sensitivity to identify patient with ARVC/D. Signal and wall motion parameters of CMR should be considered together to achieve the best diagnostic accuracy for the diagnosis of ARVC/D.
UOC Risonanza Magnetica, G. Monasterio CNR-Tuscany Foundation, Pisa, Italy. Electronic address: aquaro@ftgm.it.
Giovanni Donato
GD
Aquaro
UOC Risonanza Magnetica, G. Monasterio CNR-Tuscany Foundation, Pisa, Italy.
Andrea
A
Barison
UOC Risonanza Magnetica, G. Monasterio CNR-Tuscany Foundation, Pisa, Italy.
Giancarlo
G
Todiere
UOC Risonanza Magnetica, G. Monasterio CNR-Tuscany Foundation, Pisa, Italy.
Chrysanthos
C
Grigoratos
Institute of Clinical Physiology, CNR, Pisa, Italy.
Lamia
L
Ait Ali
Clinical and Experimental Department of Medicine, University of Messina, Messina, Italy.
Gianluca
G
Di Bella
UOC Risonanza Magnetica, G. Monasterio CNR-Tuscany Foundation, Pisa, Italy.
Michele
M
Emdin
UOC Risonanza Magnetica, G. Monasterio CNR-Tuscany Foundation, Pisa, Italy.
Pierluigi
P
Festa
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019571:Arrhythmogenic Right Ventricular Dysplasia / Q000175:diagnosis* / Q000208:ethnology / Q000503:physiopathology; D005006:Ethnicity; D005260:Female; D006352:Heart Ventricles / Q000000981:diagnostic imaging* / Q000503:physiopathology; D006801:Humans; D007558:Italy / Q000453:epidemiology; D019028:Magnetic Resonance Imaging, Cine / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000473:pathology*; D011237:Predictive Value of Tests; D015995:Prevalence; D012372:ROC Curve; D012189:Retrospective Studies; D013318:Stroke Volume / Q000502:physiology*; D016278:Ventricular Function, Right / Q000502:physiology*